ACSL4 and familial pancreatic carcinoma: Additionally, Qi et al.’s study [10] revealed that CAFs inhibit ferroptosis in pancreatic cancer cells by secreting extracellular vesicles delivering ACSL4-targeted miRNAs, inducing gemcitabine resistance.